About Qubit Pharmaceuticals
Qubit Pharmaceuticals is a company based in Paris (France) founded in 2020 by Jay Ponder, Piquemal, Louis Lagardere, Matthieu Montes, and Pengyu Ren.. Qubit Pharmaceuticals has raised $17.2 million across 3 funding rounds from investors including EIT Health, European Union and XAnge. Qubit Pharmaceuticals offers products and services including Atlas, Sirius, TINKER-HP, and Hyperion. Qubit Pharmaceuticals operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Paris, France
- Founders Jay Ponder, Piquemal, Louis Lagardere, Matthieu Montes, Pengyu Ren
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.2 M (USD)
in 3 rounds
-
Latest Funding Round
$2.49 M (USD), Grant
Sep 01, 2022
-
Investors
EIT Health
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qubit Pharmaceuticals
Qubit Pharmaceuticals offers a comprehensive portfolio of products and services, including Atlas, Sirius, TINKER-HP, and Hyperion. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables high-resolution simulations for drug candidate discovery and optimization.
Provides AI for generative and predictive modeling of small molecules.
Accelerates simulations using polarizable force fields for drug development.
Develops algorithms for quantum chemistry in drug discovery applications.
Unlock access to complete
Funding Insights of Qubit Pharmaceuticals
Qubit Pharmaceuticals has successfully raised a total of $17.2M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.49 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $2.5M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Grant - Qubit Pharmaceuticals | Valuation |
investors |
|
| Jun, 2022 | Amount | Seed - Qubit Pharmaceuticals | Valuation | XAnge | |
| Jun, 2020 | Amount | Grant - Qubit Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Qubit Pharmaceuticals
Qubit Pharmaceuticals has secured backing from 6 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include EIT Health, European Union and XAnge. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on tech companies
|
Founded Year | Domain | Location | |
|
Quantonation is recognized as a venture capital fund focused on quantum and physics-based technologies.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on energy transition and sustainable investments across Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Qubit Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Qubit Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Qubit Pharmaceuticals Comparisons
Competitors of Qubit Pharmaceuticals
Qubit Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Qubit Pharmaceuticals
Frequently Asked Questions about Qubit Pharmaceuticals
When was Qubit Pharmaceuticals founded?
Qubit Pharmaceuticals was founded in 2020.
Where is Qubit Pharmaceuticals located?
Qubit Pharmaceuticals is headquartered in Paris, France.
Is Qubit Pharmaceuticals a funded company?
Qubit Pharmaceuticals is a funded company, having raised a total of $17.2M across 3 funding rounds to date.
What does Qubit Pharmaceuticals do?
Qubit Pharmaceuticals was founded in 2020 in Paris, France, as a developer in the pharmaceutical sector. Novel drug candidates are created for oncology, inflammatory diseases, and pandemic response. Software and AI-enhanced medicinal chemistry are employed to support these efforts, focusing on targeted treatments within the biotechnology industry. Operations are centered in Europe, with an emphasis on computational drug discovery methods.
Who are the top competitors of Qubit Pharmaceuticals?
Qubit Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Qubit Pharmaceuticals offer?
Qubit Pharmaceuticals offers Atlas, Sirius, TINKER-HP, and Hyperion.
Who are Qubit Pharmaceuticals's investors?
Qubit Pharmaceuticals has 6 investors. Key investors include EIT Health, European Union, XAnge, Quantonation, and Octave Klaba.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.